{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:07:28Z","timestamp":1792382848370,"version":"4.4.0"},"reference-count":44,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec><jats:label\/><jats:p>Here, we evaluated the prevalence of Human Papillomavirus (HPV) in two groups of Chilean women. The first group consisted of 3235 women aged 18\u201064 years attended in six primary care centers of Santiago. The second group consisted of 456 women 18\u201085 aged who consulted the Gynaecology Department of the Reference Hospital of Santiago. Samples were collected from October 2012 to February 2016. Cervical swabs were analyzed both HPV genotyping by PCR and Reverse Line Blot, and cervical cytology by Pap testing. Results showed a prevalence of 12.0% HPV positive, 10.3% high\u2010risk (HR) HPV types positive, 3.9% low\u2010risk (LR) HPV types positive, and 1.0% Pap positive in group 1. The most frequent types were 16, 66, and 59, with a prevalence of 3.0%, 1.6%, and 1.5%, respectively. The prevalence were 71.9% HPV positive, 67.3% HR\u2010HPV types positive, 13.6% LR\u2010HPV types positive, and 62.5% Pap positive in group 2. The most frequent types were 16, 31, and 58, with prevalence of 33.6%, 10.5%, and 7.0%, respectively. Among infected women with HPV: 7.6% were infected with HPV16 or HPV18, 3.0% with HPV31, HPV33 or HPV45, and 6.7% with any other HR\u2010HPV. These findings show great difference in HPV prevalence and types between primary care and reference center, and provide useful epidemiological information to assess the impact of HPV vaccination in the future.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.24805","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T11:37:55Z","timestamp":1489232275000},"page":"1646-1653","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016"],"prefix":"10.1002","volume":"89","author":[{"given":"Nicol\u00e1s","family":"Vergara","sequence":"first","affiliation":[{"name":"Secci\u00f3n Virus Oncog\u00e9nicos, Subdepto. de Enfermedades Virales Instituto de Salud P\u00fablica de Chile Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Espinoza","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Atenci\u00f3n Primaria Servicio de Salud Metropolitano Central Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat","family":"Balanda","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Virus Oncog\u00e9nicos, Subdepto. de Enfermedades Virales Instituto de Salud P\u00fablica de Chile Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Quiero","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Atenci\u00f3n Primaria Servicio de Salud Metropolitano Central Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Hidalgo","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Salud Municipalidad de Huechuraba Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"San Mart\u00edn","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Virus Oncog\u00e9nicos, Subdepto. de Enfermedades Virales Instituto de Salud P\u00fablica de Chile Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Laboratorio Cl\u00ednico Hospital San Juan de Dios Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-7928","authenticated-orcid":false,"given":"Eugenio","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Virus Oncog\u00e9nicos, Subdepto. de Enfermedades Virales Instituto de Salud P\u00fablica de Chile Santiago Chile"},{"name":"Programa de Virolog\u00eda, ICBM, Facultad de Medicina Universidad de Chile Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60022-7"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"e_1_2_6_4_1","unstructured":"LBruni LBarrionuevo\u2010Rosas GAlbero et al.2016. ICO Information Centre on HPV and Cancer (HPV Information Centre) Human Papillomavirus and Related Diseases in the World. Summary Report 2015\u201012\u201023.http:\/\/www.hpvcentre.net\/summaryreport.php. Accessed 09 February 2016."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25516"},{"key":"e_1_2_6_6_1","unstructured":"Chile Ministry of Health.2016. Departamento de Estad\u00edsticas e Informaci\u00f3n de Salud. Mortalidad.http:\/\/www.deis.cl\/estadisticas\u2010mortalidad\/?p\u2009=\u200951. Accessed 11 February 2016."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr015"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.3.902-907.2002"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2005001100011"},{"key":"e_1_2_6_11_1","unstructured":"World Health Organization.2010. Human papillomavirus laboratory manual First edition. WHO\/IVB\/10.12.http:\/\/whqlibdoc.who.int\/hq\/2010\/WHO_IVB_10.12_eng.pdf. Accessed 12 February 2016."},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/1055-9965.2271.13.12","article-title":"Population\u2010based prevalence and age distribution of human papillomavirus among women in Santiago, Chile","volume":"13","author":"Ferreccio C","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27662"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-010-9598-2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0129"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.07.092"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.OLQ.0000085181.25063.6C"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22757"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600442"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23670"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70731-8"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.581"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107675"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/657321"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27608"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2014.15.23.10061"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-89102010000500023"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.008436"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23282"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomavirus","volume":"38","author":"Gravitt PE","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-440"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2399-y"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.07.015"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025493"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23509"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061825"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70187-1"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.014"},{"key":"e_1_2_6_40_1","unstructured":"European Medicines Agency.2014. Gardasil (human papillomavirus vaccine [types 6 11 16 18] recombinant adsorbed): summary of product characteristics.http:\/\/www.ema.europa.eu\/ema\/. Accessed 4 April 2016."},{"key":"e_1_2_6_41_1","unstructured":"European Medicines Agency.2015. Cervarix (human papillomavirus vaccine [types 16 18] (recombinant adjuvanted adsorbed): summary of product characteristics.http:\/\/www.ema.europa.eu\/ema\/. Accessed 4 April 2016."},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eov003"},{"key":"e_1_2_6_44_1","first-page":"300","article-title":"Use of 9\u2010valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky E","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24805","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.24805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T23:32:52Z","timestamp":1696375972000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1002\/jmv.24805"],"URL":"https:\/\/doi.org\/10.1002\/jmv.24805","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}